BE886998A - Composition pharmaceutique a effet prolonge et son procede de preparation - Google Patents

Composition pharmaceutique a effet prolonge et son procede de preparation

Info

Publication number
BE886998A
BE886998A BE0/203426A BE203426A BE886998A BE 886998 A BE886998 A BE 886998A BE 0/203426 A BE0/203426 A BE 0/203426A BE 203426 A BE203426 A BE 203426A BE 886998 A BE886998 A BE 886998A
Authority
BE
Belgium
Prior art keywords
effecting
preparing
long
same
pharmaceutical composition
Prior art date
Application number
BE0/203426A
Other languages
English (en)
French (fr)
Inventor
J Dunn
J Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of BE886998A publication Critical patent/BE886998A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/203426A 1980-01-11 1981-01-08 Composition pharmaceutique a effet prolonge et son procede de preparation BE886998A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (1)

Publication Number Publication Date
BE886998A true BE886998A (fr) 1981-07-08

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/203426A BE886998A (fr) 1980-01-11 1981-01-08 Composition pharmaceutique a effet prolonge et son procede de preparation

Country Status (22)

Country Link
JP (1) JPS56103110A (h)
AT (1) AT374681B (h)
AU (1) AU542824B2 (h)
BE (1) BE886998A (h)
CA (1) CA1140466A (h)
CH (1) CH646604A5 (h)
DE (1) DE3100191A1 (h)
DK (1) DK6181A (h)
ES (2) ES498369A0 (h)
FI (1) FI76927C (h)
FR (1) FR2473308B1 (h)
GB (1) GB2067072B (h)
GR (1) GR73843B (h)
IE (1) IE50806B1 (h)
IN (1) IN151913B (h)
IT (1) IT1221041B (h)
LU (1) LU83052A1 (h)
NL (1) NL8100037A (h)
NO (1) NO156153C (h)
NZ (1) NZ195933A (h)
SE (1) SE447450B (h)
ZA (1) ZA81136B (h)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3486029T2 (de) * 1983-10-14 1993-05-13 Sumitomo Pharma Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
CA1277601C (en) * 1985-12-27 1990-12-11 Shigeji Sato Method for producing sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
BE604564A (h) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
FI76927B (fi) 1988-09-30
GB2067072A (en) 1981-07-22
FR2473308A1 (fr) 1981-07-17
JPS56103110A (en) 1981-08-18
GR73843B (h) 1984-05-07
NO156153C (no) 1987-08-05
IE50806B1 (en) 1986-07-23
NO810062L (no) 1981-07-13
FI810056L (fi) 1981-07-12
ZA81136B (en) 1982-01-27
DK6181A (da) 1981-07-12
CH646604A5 (fr) 1984-12-14
IT1221041B (it) 1990-06-21
IN151913B (h) 1983-09-03
AU542824B2 (en) 1985-03-14
ES8205353A1 (es) 1982-06-01
DE3100191C2 (h) 1988-09-01
SE447450B (sv) 1986-11-17
ES509179A0 (es) 1982-12-16
NO156153B (no) 1987-04-27
NL8100037A (nl) 1981-08-03
DE3100191A1 (de) 1981-12-10
IE810036L (en) 1981-07-11
ATA5481A (de) 1983-10-15
CA1140466A (en) 1983-02-01
NZ195933A (en) 1982-11-23
GB2067072B (en) 1983-08-10
SE8100104L (sv) 1981-07-12
AT374681B (de) 1984-05-25
ES498369A0 (es) 1982-06-01
LU83052A1 (fr) 1982-09-10
ES8301629A1 (es) 1982-12-16
FR2473308B1 (fr) 1985-07-19
FI76927C (fi) 1989-01-10
IT8147537A0 (it) 1981-01-09
AU6597681A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
DE3166619D1 (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
FR2473308B1 (fr) Composition pharmaceutique a effet prolonge et son procede de preparation
PL232259A1 (en) Process for preparing pharmaceutical preparation
LU81482A1 (fr) Procede de preparation de d-camphorate de l-carnitinamide et de d-camphorate de d-carnitinamide
DE3063368D1 (en) Polymers and process for their preparation
FR2518115B1 (fr) Composition de blanchiment peroxygenee et son procede de preparation
DE3060861D1 (en) Monophosphonate compounds, process for their preparation and pharmaceutical compositions containing them
PT76853A (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
FR2518091B1 (fr) 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant
DE3062989D1 (en) Triazolylphenacyl-pyridyl-ether derivatives, process for their preparation and their application as fungicides
PT72713B (fr) Procede de preparation de malathion
MA18466A1 (fr) Fongicides et procede pour leur preparation
BE877866A (fr) Produit pesticide granulaire et son procede de preparation
FR2488874B1 (fr) Produit de revetement et son procede de preparation
FR2518092B1 (fr) Composes de trihydroxyvitamine d3, leur procede de preparation et composition pharmaceutique les renfermant
YU42829B (en) Process for obtaining laxating compounds of the senna drug
EP0058204A4 (en) DEOXIDATING AGENT AND METHOD FOR THE PRODUCTION THEREOF.
EP0042092A3 (en) 1,4-dihydropyridine-4-carboxamides, process for preparing them, their use as medicines and preparation thereof
FR2491932B1 (fr) Polyurethane moule par reaction et son procede de preparation
DE3161794D1 (en) 2-fluorophenyl-(di)thiophosphoric-acid esters, process for their preparation and their use as pesticides
BE886310A (fr) Composition pharmaceutique injectable a action prolongee et son procede de preparation
DE3161427D1 (en) N-allenylalkyl-acetanilides, process for their preparation and their use as fungicides
DE3164432D1 (en) Pyrazolobenzazepines, process for their preparation and pharmaceutical compositions containing them
PT72338A (en) Process for the preparation of 2-aminomethyl-6-halophenolshaving pharmaceutical effect